<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045976"><TermName>carmustine</TermName><TermPronunciation>(kar-MUS-teen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat certain types of brain tumors. It is also used with prednisone to treat multiple myeloma and with other drugs to treat Hodgkin lymphoma and non-Hodgkin lymphoma that have not gotten better with other treatment or have come back. It is also being studied in the treatment of other types of cancer. Carmustine damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called BCNU and BiCNU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731329" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;carmustine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731328" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;carmustina&quot;" language="es" id="_4"/><SpanishTermName>carmustina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar ciertos tipos de tumores cerebrales. También se usa con prednisona para tratar el mieloma múltiple y, con otros medicamentos, para tratar el linfoma de Hodgkin y el linfoma no Hodgkin que no mejora con otro tratamiento o que vuelve. También está en estudio para el tratamiento de otros tipos de cáncer. La carmustina daña el ADN celular y puede destruir células cancerosas. Es un tipo de alquilante y de nitrosourea. También se llama BCNU y BiCNU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2014-06-19</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000761705">Carmustine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
